Press releases

Medicine used to treat multiple sclerosis also helps in a rare form of genetic epilepsy - drug precisely targets underlying genetic defect

Read more

Press release in German only

Read more

Press release in German only

Read more

Press release in German only

Read more

Press release in German only

Read more

Press release in German only

Read more

Press release in German only

Read more

The chain reaction which leads to toxic protein deposits in Alzheimer’s disease starts even earlier than assumed. Researchers from Tübingen show how…

Read more

Professor Mathias Jucker from the Hertie Institute for Clinical Brain Research and the German Center for Neurodegenerative Diseases shares the…

Read more

Press release in German only

Read more
Press contact
Press contactDirector of Communications
Silke DutzTelefon 07071 29 88802silke.dutz@medizin.uni-tuebingen.deAddress

Hertie Institute for Clinical Brain Research
Director of Communications

Otfried-Müller-Str. 27
72076 Tübingen